rs3135027
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
Variant has been reported in ClinVar as Benign (★★).
Frequency
Mitomap GenBank:
𝑓 0.011 ( AC: 662 )
Consequence
RNR1
non_coding_transcript_exon
non_coding_transcript_exon
Scores
Clinical Significance
No linked disesase in Mitomap
Conservation
PhyloP100: -2.39
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant M-1598-G-A is Benign according to our data. Variant chrM-1598-G-A is described in ClinVar as [Benign]. Clinvar id is 42223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
High frequency in mitomap database: 0.0108
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNR1 | unassigned_transcript_4786 use as main transcript | n.951G>A | non_coding_transcript_exon_variant | 1/1 | ||||
TRNV | unassigned_transcript_4787 use as main transcript | c.-4G>A | upstream_gene_variant | |||||
use as main transcript |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap GenBank
AF:
AC:
662
Gnomad homoplasmic
AF:
AC:
377
AN:
56401
Gnomad heteroplasmic
AF:
AC:
8
AN:
56401
Mitomap
No disease associated.
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 14, 2012 | m.1598G>A in MTRNR1: This variant is not expected to have clinical significance because it is reported at a frequency ranging from 0.6% to 12.5% across a broad multi-ethnic population (mtDB: http://www.mtdb.igp.uu.se/index.html, MitoMap: h ttp://www.mitomap.org/MITOMAP). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at